Purified Anti-Human CD134 Antibody[Ber-ACT35]

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell prolifeRation and differentiation.

IMD;ACT;Tumor necrosis factor receptor superfamily member;Txgp;TNFRSF;TNFRSF4;ACT35;CD134;IMD16;OX40;TXGP1L;ACT35 antigen;OX40L receptor;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (C-Fc-Avi);Recombinant Human OX40/TNFRSF4 Protein (C-mFc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc);Tumor necrosis factor receptor superfamily member 4;Txgp1;OX-40; TNFRSF4;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc)

P43489

Recombinant Human CD134 protein

Ber-ACT35

Mouse

Human

Mouse IgG1,κ

Verified Samples in FCM: HEK293T cells transfected with pcDNA3.1 plasmid encoding Human CD134 gene

FCM 2 μg/mL(1×10⁵-5×10⁵ cells)

Unconjugated

≥ 1 mg/mL

>98%, Protein A/G purified

FCM

Monoclonal

PBS, pH 7.2. Contains 0.05% proclin 300.

Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

12个月

Ice bag